Measles cases are rising in the United States after falling vaccination rates, with 2025 described as the highest count since measles was eliminated in 2000 and 2026 already showing a higher tally by early November. Outlets report that the spread is broad across many states, with Pennsylvania highlighted among the hardest hit areas in terms of reported deaths.
Multiple reports point to a Johns Hopkins University tool that estimates the economic impact of the 2025 outbreak. It places the cost at more than $37 million for 2025 and nearly $83 million overall, breaking down spending between public health response, lost productivity, and medical expenses. The analysis also describes cost patterns, including higher costs associated with initial mobilization for outbreaks and additional costs as more cases are identified.
While one outlet emphasizes the broader national health and state-level toll alongside the economic estimates, another focuses more directly on the message that measles outbreaks can carry million-dollar price tags. Both also frame the surge as connected to changes in vaccination coverage and note the relevance of CDC reporting and ongoing reviews of measles elimination status.
